Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Lancet. Infectious Diseases (Print)

• Publication date

  2017-09-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S1473-3099(17)30234-7PMID 28461209PMCID PMC5856335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac MRI Findings Suggest Myocarditis in Severe Ebola Virus Disease.

  2017cited by this paper
• Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

  2017cited by this paper
• Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report

  2017cited by this paper
• Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data.

  2016cited by this paper
• A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

  2016cited by this paper
• Moving Towards a More Aggressive and Comprehensive Model of Care for Children with Ebola.

  2016cited by this paper
• Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

  2016cited by this paper
• Clinical Chemistry of Patients With Ebola in Monrovia, Liberia.

  2016cited by this paper
• Progression of Ebola Therapeutics During the 2014-2015 Outbreak.

  2016cited by this paper
• Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.

  2016cited by this paper
• Sequelae of Ebola virus disease: the emergency within the emergency.

  2016cited by this paper
• On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa.

  2016cited by this paper
• Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study.

  2016cited by this paper
• Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

  2016cited by this paper
• Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.

  2016cited by this paper
• Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015

  2016cited by this paper
• Experimental Treatment of Ebola Virus Disease with Brincidofovir

  2016cited by this paper
• Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

  2016cited by this paper
• Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.

  2016cited by this paper
• Late Ebola virus relapse causing meningoencephalitis: a case report

  2016cited by this paper
• Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients.

  2016cited by this paper
• Changes in the primary outcome in Ebola vaccine trial--Authors' reply.

  2016cited by this paper
• Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control

  2016cited by this paper
• Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial

  2016cited by this paper
• Post-Ebola Syndrome, Sierra Leone

  2016cited by this paper
• Minimally Symptomatic Infection in an Ebola ‘Hotspot’: A Cross-Sectional Serosurvey

  2016cited by this paper
• Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015

  2016cited by this paper
• Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone

  2016cited by this paper
• Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations

  2016cited by this paper
• Ebola Virus Disease among Male and Female Persons in West Africa.

  2016cited by this paper
• Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease.

  2016cited by this paper
• Inappropriate bradycardia in Ebola virus disease.

  2016cited by this paper
• Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa

  2016cited by this paper
• Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study

  2016cited by this paper
• Ebola Virus Disease in Children, Sierra Leone, 2014–2015

  2016influential reference
• Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days

  2016cited by this paper
• Delivery of an Ebola Virus-Positive Stillborn Infant in a Rural Community Health Center, Sierra Leone, 2015.

  2016cited by this paper
• Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in Guinea.

  2016cited by this paper
• Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.

  2016cited by this paper
• Pregnancy outcomes in Liberian women who conceived after recovery from Ebola virus disease.

  2016cited by this paper
• After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.

  2016cited by this paper
• Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies.

  2016cited by this paper
• Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.

  2016cited by this paper
• Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

  2016cited by this paper
• Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.

  2016cited by this paper
• Clinical Management of Ebola Virus Disease in the United States and Europe.

  2016influential reference
• Post-Ebola syndrome.

  2016cited by this paper
• Sequelae of Ebola Virus Disease, Kenema District, Sierra Leone.

  2016cited by this paper
• Ebola Virus-Related Encephalitis.

  2016cited by this paper
• West Africa 2013: Re-examining Ebola

  2016cited by this paper
• After Ebola in West Africa — Unpredictable Risks, Preventable Epidemics

  2016cited by this paper
• Resurgence of Ebola virus disease in guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days

  2016cited by this paper
• The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June–October 2014

  2015cited by this paper
• Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis

  2015cited by this paper
• Organ failures on admission in patients with Ebola virus disease

  2015cited by this paper
• Molecular mechanisms of Ebola virus pathogenesis: focus on cell death

  2015cited by this paper
• Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study.

  2015cited by this paper
• Persistence of Ebola Virus in Ocular Fluid during Convalescence.

  2015cited by this paper
• A Pregnant Patient With Ebola Virus Disease

  2015cited by this paper
• Sexual and mother-to-child transmission of Ebola virus in the postconvalescent period.

  2015cited by this paper
• Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination.

  2015cited by this paper
• Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates

  2015cited by this paper
• Ebola: Embed research in outbreak response

  2015cited by this paper
• An evaluation of psychological distress and social support of survivors and contacts of Ebola virus disease infection and their relatives in Lagos, Nigeria: a cross sectional study − 2014

  2015cited by this paper
• Clinical predictors of mortality in patients with Ebola virus disease.

  2015cited by this paper
• Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

  2015cited by this paper
• Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report.

  2015cited by this paper
• West African Ebola epidemic after one year--slowing but not yet under control.

  2015cited by this paper
• Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement.

  2015cited by this paper
• Ebola Virus Disease among Children in West Africa

  2015cited by this paper
• Clinical presentation of patients with Ebola virus disease in Conakry, Guinea.

  2015cited by this paper
• Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study.

  2015cited by this paper
• Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak

  2015cited by this paper
• Study of Ebola Virus Disease Survivors in Guinea.

  2015cited by this paper
• Ebola virus disease complicated with viral interstitial pneumonia: a case report

  2015cited by this paper
• Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers

  2015cited by this paper
• Molecular Evidence of Sexual Transmission of Ebola Virus.

  2015cited by this paper
• Difficulties of interpretation of Zaire Ebola Virus PCR results and implication in the field.

  2015cited by this paper
• Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.

  2015influential reference
• Blood kinetics of Ebola virus in survivors and nonsurvivors.

  2015cited by this paper
• Severe Ebola virus infection complicated by gram-negative septicemia.

  2015influential reference
• Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report.

  2015cited by this paper
• Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study

  2015cited by this paper
• Ebola viral disease and pregnancy

  2015cited by this paper
• A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

  2015cited by this paper
• Ebola virus disease among children in West Africa.

  2015cited by this paper
• West African Ebola Epidemic after One Year — Slowing but Not Yet under Control

  2015cited by this paper
• Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain.

  2015cited by this paper
• Ebola in Freetown area, Sierra Leone--a case study of 581 patients.

  2015cited by this paper
• Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report.

  2015cited by this paper
• Post-Ebola Signs and Symptoms in U.S. Survivors.

  2015cited by this paper
• Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care.

  2015cited by this paper
• Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo

  2015cited by this paper
• Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients

  2015cited by this paper
• Epidemiology and risk factors for Ebola virus disease in Sierra Leone-23 May 2014 to 31 January 2015.

  2015cited by this paper
• Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States

  2015cited by this paper
• The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola

  2015cited by this paper
• Clinical Features of Patients With Ebola Virus Disease in Sierra Leone.

  2015cited by this paper
• Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports

  2015cited by this paper
• Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States*

  2015cited by this paper

• DNA Tetrahedron-Enhanced Catalytic Hairpin Assembly for In Situ Monitoring of Viral RNA in Host Cells.

  2025cites this paper
• Development of a Bayesian Subjective Model for Predicting the Clinical Diagnosis of Ebola in the Democratic Republic of the Congo

  2025cites this paper
• Molecular virulence determinants of human-pathogenic filoviruses.

  2025cites this paper
• Research prioritisation in preparedness for and response to outbreaks of high-consequence pathogens: a scoping review

  2025cites this paper
• Integrative role of small non-coding RNAs in viral immune response: a systematic review

  2024cites this paper
• Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation.

  2023cites this paper
• The COVID-19 pandemic in sub-Saharan Africa: The significance of presumed immune sufficiency

  2023cites this paper
• Ebola virus disease in children: epidemiology, pathogenesis, management, and prevention

  2023cites this paper
• The Marburg virus outbreak in West Africa.

  2023cites this paper
• AntiV‐SGN: a universal antiviral strategy to combat both RNA and DNA viruses by destroying their nucleic acids without sequence limitation

  2022cites this paper
• Global challenges in preparedness and response to epidemic infectious diseases

  2022cites this paper
• Lateral Flow Immunoassays for Detecting Viral Infectious Antigens and Antibodies

  2022cites this paper
• Exotic viral hepatitis; a review on epidemiology, pathogenesis, and treatment.

  2022cites this paper
• Sensor System Based on a Piezoelectric Resonator with a Lateral Electric Field for Virus Diagnostics.

  2022cites this paper
• A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic

  2021cites this paper
• Politics of disease control in Africa and the critical role of global health diplomacy: A systematic review

  2021cites this paper
• Promoting and measuring remyelination and neuroprotection in clinical trials of people with multiple sclerosis

  2021cites this paper
• Advances and insights in the diagnosis of viral infections

  2021cites this paper
• Africa and the Nexus of poverty, malnutrition and diseases

  2021cites this paper
• Clinical presentations, diagnostics, treatments and treatment costs of children and adults with febrile illness in a tertiary referral hospital in south-eastern Guinea: A retrospective longitudinal cohort study

  2021cites this paper
• Research directions for supply chain management in facing pandemics: an assessment based on bibliometric analysis and systematic literature review

  2021cites this paper
• Do Social Connections and Digital Technologies Act as Social Cure During COVID-19?

  2021cites this paper
• A scoping review on research agendas to enhance prevention of epidemics and pandemics in Africa.

  2020cites this paper
• Viral Hemorrhagic Fevers

  2020cites this paper
• Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients

  2020influential citation
• Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks

  2020cites this paper
• Treatment of Ebola-related critical illness

  2020cites this paper
• Ebola virus disease

  2020cites this paper
• Repurposing therapeutic agents and herbal medicines to defeat viral nemesis

  2020cites this paper
• The Plasma Mobile, ‘A gift from heaven’: The impact of health technology transfer on trial perceptions and expectations during the Ebola-Tx Trial, Conakry

  2020cites this paper
• Antiretroviral HIV drugs in COVID19 research: promises and risks. An opinion piece

  2020cites this paper
• COVID‐19 research: an opinion piece

  2020cites this paper
• How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis

  2020cites this paper
• Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda

  2020cites this paper
• Quantification of Ebola virus replication kinetics in vitro

  2020cites this paper
• Period prevalence and identification challenges of viral haemorrhagic fever suspect cases in a tertiary referral hospital in Guinea: a cross-sectional, retrospective study of triage and emergency room patient profiles

  2020cites this paper
• A scoping review on research agendas to enhance prevention of epidemics and pandemics in Africa

  2020cites this paper
• Biosensors for Virus Detection

  2020cites this paper
• Early transmission and case fatality of Ebola virus at the index site of the 2013–16 west African Ebola outbreak: a cross-sectional seroprevalence survey

  2019cites this paper
• Pulmonary Involvement during the Ebola Virus Disease

  2019cites this paper
• Ebola virus disease: An emerging and re-emerging viral threat.

  2019cites this paper
• Computer-designed orthogonal RNA aptamers programmed to recognize Ebola virus glycoproteins

  2019cites this paper
• Principles and Practices of Establishing a Hospital-Based Ebola Treatment Unit.

  2019cites this paper
• Clinical trials in an Ebola outbreak seek to find an evidence-based cure

  2019cites this paper
• Therapeutic strategies to target the Ebola virus life cycle

  2019cites this paper
• A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic

  2019cites this paper
• A new twenty-first century science for effective epidemic response

  2019cites this paper
• Knowledge, attitudes and practices towards viral haemorrhagic fevers amongst healthcare workers in urban and rural public healthcare facilities in the N’zérékoré prefecture, Guinea: a cross-sectional study

  2019cites this paper
• Ebola Virus Disease

  2019cites this paper
• Viral Therapeutics

  2019cites this paper
• Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies

  2018cites this paper
• When do co-infections matter?

  2018cites this paper
• Applications of gold nanoparticles in virus detection

  2018cites this paper
• Research priorities during infectious disease emergencies in West Africa

  2018influential citation
• Effects of the West African Ebola Epidemic on Health Care of Pregnant Women: Stigmatization With and Without Infection

  2018cites this paper
• ESTRÉS TÉRMICO EN PROFESIONALES DE EMERGENCIAS DURANTE LA REALIZACIÓN DE UNA REANIMACIÓN CON EQUIPOS DE PROTECCIÓN FRENTE A RIESGOS BIOLÓGICOS

  2018cites this paper
• Emerging infectious diseases in Africa in the 21st century

  2018cites this paper
• Does Gender Influence Physiological Tolerance in Resuscitators When Using Personal Protection Equipment against Biological Hazards?

  2018cites this paper
• Surveillance in the field: Over-identification of Ebola suspect cases and its contributing factors in West African at-risk contexts

  2018cites this paper
• Performance of different clinical trial designs to evaluate treatments during an epidemic

  2018cites this paper
• What treating Ebola means for pandemic influenza

  2018cites this paper
• Filovirus – Auslöser von hämorrhagischem Fieber

  2018cites this paper
• Initiation and publication time-lags of treatment trials for Ebola virus disease.

  2018cites this paper
• Clinician-initiated research on treating the host response to pandemic influenza

  2018cites this paper
• Management of Ebola Virus Disease in Children.

  2017cites this paper
• HERD IMMUNITY TO EBOLAVIRUSES IS NOT A 1 REALISTIC TARGET FOR CURRENT VACCINATION 2 STRATEGIES 3 4

  year unknowncites this paper